Status:
COMPLETED
Cohort of Inflammatory Bowel Disease Patient in Yeouido St. Mary's Hospital
Lead Sponsor:
Yeouido St. Mary's Hospital
Conditions:
Inflammatory Bowel Diseases
Eligibility:
All Genders
Up to 75 years
Brief Summary
Pathologically Inflammatory bowel disease (IBD) is in chronic complex inflammatory gut pathological condition. Although the etiology of IBD is unknown, gut microbiota alteration (dysbiosis) is conside...
Detailed Description
Inflammatory bowel disease (IBD) (Crohn's disease (CD) and ulcerative colitis (UC)) occurs worldwide with differences in epidemiology, etiology, and phenotype between regions. Pathologically Inflammat...
Eligibility Criteria
Inclusion
- The below 3 conditions must be met simultaneously.
- Patient who can voluntarily consent to this study.
- Patient who has inflammatory bowel disease.
- Patient who is aged less than 75 years.
Exclusion
- a patient meets any of the below conditions.
- If a patient has an IBD other than UC and CD.
- If a patient is vulnerable due to his/her position as an employee of Yeouido St.Mary's hospital or a medical student of the Catholic University of Korea.
- If a patient is pregnant.
- Foreign personal who cannot speak Korean.
Key Trial Info
Start Date :
October 26 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 24 2023
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT05183256
Start Date
October 26 2020
End Date
July 24 2023
Last Update
July 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yeouido St. Mary's hospital
Seoul, South Korea, 07241